We are live on ! Find out more
WP

WMS Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 11.82%
This Fund
S&P 500
This Quarter Est. Return
-6.83%
1 Year Est. Return
+11.82%
3 Year Est. Return
+10.77%
5 Year Est. Return
+74.56%
10 Year Est. Return
+198.1%
AUM
$655M
AUM Growth
-$205M
Cap. Flow
-$147M
Cap. Flow %
-22.4%
Top 10 Hldgs %
37.21%
Holding
290
New
10
Increased
23
Reduced
135
Closed
87

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$56.8M
2
XOM icon
ExxonMobil
XOM
+$4.9M
3
ANSS
Ansys
ANSS
+$3.6M
4
VTV icon
Vanguard Value ETF
VTV
+$3.06M
5
VUG icon
Vanguard Growth ETF
VUG
+$3.06M

Sector Composition

Rank Sector Weight
1 Technology 14.93%
2 Industrials 14.35%
3 Healthcare 13.17%
4 Financials 9.88%
5 Real Estate 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
176
Stryker
SYK
$122B
$241K 0.04%
2,562
+178
+7% +$17.6K
VMI icon
177
Valmont Industries
VMI
$10.2B
$237K 0.04%
2,500
BA icon
178
Boeing
BA
$165B
$236K 0.04%
1,804
-1,150
-39% -$160K
RSG icon
179
Republic Services
RSG
$67.8B
$236K 0.04%
5,725
-2,825
-33% -$116K
UDN icon
180
Invesco DB US Dollar Index Bearish Fund
UDN
$108M
$235K 0.04%
10,700
DD
181
DELISTED
Du Pont De Nemours E I
DD
$234K 0.04%
4,862
-2,608
-35% -$139K
CCI icon
182
Crown Castle
CCI
$34.1B
$229K 0.04%
2,900
-95
-3% -$7.72K
LMT icon
183
Lockheed Martin
LMT
$117B
$227K 0.03%
1,096
-5
-0.5% -$1.02K
MCHP icon
184
Microchip Technology
MCHP
$43.7B
$226K 0.03%
10,494
-5,450
-34% -$117K
NYMX
185
DELISTED
Nymox Pharmaceutical Corp
NYMX
$226K 0.03%
65,555
-400
-0.6% -$931
MACK
186
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$218K 0.03%
3,254
ADP icon
187
Automatic Data Processing
ADP
$102B
$217K 0.03%
2,701
-4,238
-61% -$339K
BYBK
188
DELISTED
Bay Bancorp, Inc.
BYBK
$217K 0.03%
42,593
IDXX icon
189
Idexx Laboratories
IDXX
$44.5B
$212K 0.03%
2,858
-1,226
-30% -$87.8K
TEVA icon
190
Teva Pharmaceuticals
TEVA
$36.1B
$210K 0.03%
3,718
-4,321
-54% -$280K
MET icon
191
MetLife
MET
$59.8B
$208K 0.03%
4,948
-3,333
-40% -$156K
BCE icon
192
BCE
BCE
$20.2B
$205K 0.03%
5,000
GM icon
193
General Motors
GM
$68.3B
$204K 0.03%
+6,787
New +$208K
PATI
194
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$201K 0.03%
8,338
PNFP icon
195
Pinnacle Financial Partners Inc
PNFP
$15B
$200K 0.03%
+4,050
New +$205K
F icon
196
Ford
F
$55.7B
$196K 0.03%
14,475
-140
-1% -$2K
UPLD icon
197
Upland Software
UPLD
$14.5M
$170K 0.03%
+2,155
New +$174K
EMO
198
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
$162K 0.02%
2,253
FCX icon
199
Freeport-McMoran
FCX
$84.5B
$126K 0.02%
+13,000
New +$156K
GNW icon
200
Genworth Financial
GNW
$3.87B
$62K 0.01%
13,350
-3,525
-21% -$20.7K

Similar funds

WMS Partners's Q3 2015 Portfolio in Review

As of Q3 2015, WMS Partners held 290 positions worth $655M, down 24% from $860M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

WMS Partners withdrew a net $147M in Q3 2015, closing 87 positions and reducing 135 holdings. Its most notable exit was Ansys, an estimated $3.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, WMS Partners opened a new position in Supernus Pharmaceuticals worth $912K.

  • WMS Partners's largest Q3 2015 buy was Supernus Pharmaceuticals: 65,031 shares worth $912K.
  • WMS Partners added most to Vanguard Total Stock Market ETF in Q3 2015, an estimated $32.1M increase.
  • WMS Partners's biggest Q3 2015 reduction was T. Rowe Price, cutting an estimated $56.8M.
  • WMS Partners fully exited Ansys in Q3 2015, selling an estimated $3.6M.
  • WMS Partners's ten largest holdings make up 37% of its $655M portfolio in Q3 2015.
  • WMS Partners opened 10 new positions and closed 87 in Q3 2015.
  • WMS Partners's portfolio value fell 24% quarter-over-quarter to $655M.

Based on WMS Partners's 13F filing for Q3 2015, filed 12 Nov 2015.